Key considerations for health plan sponsors in covering family-building benefits (including in vitro fertilization (IVF)) ...

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial populations, fragmented global expectations, and production bottlenecks as ...

If these results are validated by prospective trials, it could become a valuable tool for oncologists to assess results ...

Andy Wasserman, George Russell, and the Living Lineage of the Lydian Chromatic Concept article by Patrick Doyle, published on ...

Transcript: Rare Diseases ...

Global rare disease policy shifts are reshaping orphan drug development, with major implications for equitable access in the UK, EU and US.

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsJohanna Mercier - Chief ...

Vertex Pharmaceuticals Incorporated ( VRTX) TD Cowen 46th Annual Health Care Conference March 3, 2026 9:10 AM EST ...

Marking its inaugural show at the reopened Hopkins Center for the Arts, the contemporary play opened on Friday after a term of dedication from theater department staff and students.

The run-up to the end of the tax year - April 5 - is always a crucial time to ensure long-term savings and investments are ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...